Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Biologic or biosimilar: what are prescribers thinking?

Biologic or biosimilar: what are prescribers thinking? Herceptin has been around for 12–13 years. Biosimilars are new drugs; we don’t have the same data for them.

Mylan gets first biosimilar Herceptin OK from FDA

Mylan gets first biosimilar Herceptin OK from FDA Mylan has become the first pharma company to win US approval for a biosimilar of Roche’s big-selling cancer antibody Herceptin. ... have suggested it will start making revenues from the drug in 2019 – the year in which Roche’s US patent on

First Herceptin biosimilar cleared in Europe

First Herceptin biosimilar cleared in Europe means it can now threaten the CHF 2.1bn in European sales achieved by Herceptin last year. ... Roche is claiming patent protection for Herceptin in the US out to 2019, but its EU patents expired in 2014.

Building a bright future

Building a bright future Herceptin while taking a buffeting over trading in the US, despite European growth contributing strongly to $2.96bn second quarter revenues. ... mission.”. It has manoeuvered into pole position to grab a significant slice of Roche’s $2bn-a-year

CHMP backs maintenance therapy for Tesaro's Zejula

CHMP backs maintenance therapy for Tesaro's Zejula The CHMP recommended approval of two biosimilars, namely Samsung Bioepis' Ontruzant (trastuzumab) - the first biosimilar of Roche's breast cancer therapy Herceptin to get a positive opinion in the EU - and

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics